Presentación
COAGULOPATHIES AND ALTERATIONS OF HAEMOSTASIS

alteracionesdelahemostasia@idipaz.es
Composition
Name
Position
Institution
Víctor Manuel Jiménez Yuste
Jefe de Servicio de Hematología 
Profesor Asociado 
Hospital Universitario La Paz
Universidad Autónoma de Madrid
María Teresa Álvarez Román
Jefa de Sección de Coagulopatías
Hospital Universitario La Paz
Hortensia de la Corte Rodríguez
Facultativo Especialista de Área en Hematología y Hemoterapia
Hospital Universitario La Paz
Nora Viviana Butta Coll
Investigadora Senior (Contrato Miguel Servet- Tipo 2)
Jefe de Laboratorio
Hospital Universitario La Paz
Raquel Fernández Morata
Técnico de Laboratorio
Hospital Universitario La Paz
Elena García Arias-Salgado
Investigadora Postdoctoral
FIBHULP
Sara García Barcenilla
Coordinadora de Estudios 
Hospital Universitario La Paz
Mercedes Gassior Kabat
Facultativo Especialista de Área en Hematología y Hemoterapia
Hospital Universitario La Paz
Mónica Martín Salces
Facultativo Especialista de Área en Hematología y Hemoterapia
Hospital Universitario La Paz
Elena Monzón Manzano
Investigadora Postdoctoral
FIBHULP
Isabel Rivas Pollmar
Médico Adjunto en Hematología
Hospital Universitario La Paz
Strategic Objective
This group’s research activities address various relevant questions in the area of haematology and focus on the characterisation of the genetic and molecular basis of coagulation and haemostatic function. Our group investigates physiological processes such as coagulation, haemostasis, innate immunity, inflammation, cell adhesion and migration, and cell signalling, with special emphasis on their relevance to pathological processes.
In addition, we perform epidemiological studies to facilitate patient data analysis and therapeutic treatment.
Research Lines
1- Haemophilia A and B:
• Genetic and molecular studies in patients with haemophilia A and B
• Risk factors for the development of factor FVIII/FIX inhibitors in patients with haemophilia A and B. Individualised treatment adaptation based on the nature of antigenic epitopes
• Epidemiological studies of congenital haemophilia A and B, acquired haemophilia A and von Willebrand’s disease
2-Haemostasis disorders:
• Haemostasis in thrombocytopenic diseases (immune thrombocytopenic purpura and myelodysplastic syndromes)
• Haemostasis in inflammatory diseases